Membre de la ligne de métiers Banque-Finance, Melinda Stege Arsouze est une associée de droit américain spécialisée en marchés de capitaux. Avec plus de 10 ans d'expérience, elle est intervenue sur de nombreuses offres de titres transfontalières, notamment sur des cessions de blocs, des privatisations, des opérations High Yield et des émissions d'obligations, par voie d'offres au public ou de placement privé.

Basée à Paris, Melinda parle couramment le français et travaille en étroite collaboration avec les équipes Capital Markets de Gide dans le monde, avec une expérience approfondie pour les opérations en Europe, ainsi qu’au sein de la zone EMEA, en particulier en Turquie, en Afrique du Nord et en Asie.

Melinda a rejoint le cabinet Gide à Paris en 2008 après avoir travaillé huit ans dans un cabinet d'avocats américain de tout premier plan. Elle est avocate aux Barreaux de New York et de Paris et diplômée de Columbia University (New York, Etats-Unis).

Melinda Arsouze est référencée parmi les meilleurs experts en marchés de capitaux par les guides juridiques internationaux Chambers, Legal 500 et IFLR1000.

« Gide Loyrette Nouel combines life sciences and technology-sector expertise with extensive experience handling IPOs, share capital increases and convertible bonds. It attracts high-profile public and private sector clients, including financial institutions and major corporations. Headed by Arnaud Duhamel and Melinda Stege Arsouze, the group also has capabilities in French and US law. Duhamel advised Morgan Stanley as joint global co-ordinator alongside Goldman Sachs on the global offering of ordinary shares in DBV Technologies, including a public offering of ordinary shares in the form of American Depositary Shares in the US and a private placement of ordinary shares in Europe. A recent highlight in the life sciences sector saw Stege Arsouze act for GenSight Biologics in a €22.5m global Regulation S private placement and in a Rule 144A private placement. Other clients include Inventiva, Société Générale and the Agence des participations de l'État. »
Legal 500 EMEA 2019

« Gide Loyrette Nouel has a core focus on French issuer IPOs, but also has in-depth knowledge of US instruments, including Nasdaq listings, Regulation S and 144A transactions. Arnaud Duhamel is the key adviser and cross-border specialist Melinda Stege Arsouze is particularly active in private placements in the US. »
Legal 500 EMEA 2018

« Clients highlight Melinda Stege Arsouze's 'reactiveness and availability.' She is US-qualified and her areas of expertise include IPOs, capital increases and convertible bonds. »
Chambers Global 2018

« Gide Loyrette Nouel A.A.R.P.I. demonstrates strength across the board of debt capital market financings, with 144A debt transactions by French issuers and Euro private placements areas of particular expertise. The team has a largely domestic workload but also excels in complex, cross-border matters, such as the work undertaken for Groupe FNAC on the issuance of €650m senior notes, which are governed by New York law, listed on the Irish Stock Exchange and admitted to trading on the Irish Stock Exchange’s Global Exchange Market. In another cross-border highlight, the team advised Veolia Environnement on the first issuance of a panda bond by a French issuer. Domestic highlights include advising Europcar Groupe on the issuance of 144A high-yield senior notes. Other clients include Société Générale, Gecina and BNP Paribas. Practice heads Arnaud Duhamel, Hubert Merveilleux du Vignaux and US-qualified Melinda Stege Arsouze are the key names. Laurent Vincent was promoted to counsel. »
Legal 500 EMEA 2018

« Melinda Stege Arsouze is highlighted in particular for her experience in IPOs. She is an expert on US securities law, and her recent work highlights include leading the team in advising GenSight Biologics on its IPO listing on NASDAQ. »
Chambers Global 2017

« Gide produces ‘excellent and efficient work’ and ‘knows very well the standards on the banks’ side and the needs from the issuers’ side’; it has notable experience in mandates involving the public sector. The practice recently assisted the banking syndicate with Vallourec’s €480m capital increase and advised Veolia Environnement on a €700m OCEANE issuance. Arnaud Duhamel ‘shows real judgement in difficult situations rather than sitting on the fence’ and Melinda Stege Arsouze provides US expertise’. »
Legal 500 EMEA 2017

« Gide Loyrette Nouel is ‘one of the few French firms able to compete with the Anglo-Saxon firms’, for issuer and underwriter representations alike. The practice has ‘deep knowledge of French law’ and is also able to provide US law advice including with regard to private placements and US IPOs. The team recently completed a high volume of work in the life sciences sector, notably including advising DBV Technologies SA on its Nasdaq IPO. The practice also assisted the underwriters regarding Solairedirect’s IPO on Euronext Paris and Rule 144A US offering. The team is ‘highly responsive and efficient’. Key figures in the practice include Arnaud Duhamel and Melinda Arsouze, who are both 'very good advisers'. »
Legal 500 EMEA 2016

« US-qualified Melinda Stege Arsouze handles international capital markets matters, with a particular focus on the equity side. »
Chambers Global 2016